%0 Journal Article
%@ 2369-2960
%I JMIR Publications
%V 5
%N 2
%P e12603
%T Pneumococcal Vaccination Utilization Among Hispanic Long-Term Colorectal Cancer Survivors: Cross-Sectional Assessment of Claims
%A Moran,Ryan J
%A Waalen,Jill
%A Murphy,James
%A Nalawade,Vinit
%A Schiaffino,Melody
%+ Department of Family Medicine and Public Health, University of California San Diego, 9500 Gilman Drive, Mail Code #0811, La Jolla, CA, 92093, United States, 1 8582258535, rjmoran@ucsd.edu
%K Hispanic Americans
%K cancer survivors
%K medicare
%K preventive medicine
%K pneumococcal vaccines
%D 2019
%7 13.05.2019
%9 Original Paper
%J JMIR Public Health Surveill
%G English
%X Background: Colorectal cancer (CRC) is the second leading cancer-related cause of death in the United States. However, survivorship has been increasing. Both cancer survivors and underserved populations experience unique health-related challenges and disparities that may exist among long-term CRC survivors as it relates to routine preventive care, specifically pneumococcal (PNM) vaccination. Objective: The aim of this study was to explore the relationship between long-term CRC survival and the receipt of PNM vaccine among Hispanic Medicare recipients compared with non-Hispanic populations. Methods: This study is a cross-sectional analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare claims data examining ethnic differences in the receipt of PNM vaccination among long-term CRC survivors. Multivariable logistic regression models considered Hispanic ethnicity while controlling for sociodemographic characteristics, comorbidity score, age, tumor stage, and SEER registry. Results: Our sample revealed 32,501 long-term CRC survivors, and 1509 identified as Hispanic (4.64%) based on an established SEER algorithm. In total, 16,252 CRC survivors, or 50.00% of our sample, received a PNM vaccination. We found that Hispanic CRC survivors had 10% decreased odds of having received a PNM vaccine compared with non-Hispanic survivors (P=.03). Conclusions: Disparities likely exist in the utilization of PNM vaccination among long-term CRC survivors. Among Medicare beneficiaries, the use of claims data regarding PNM vaccination highlights the relatively poor utilization of guideline-directed preventive care. 
%M 31094341
%R 10.2196/12603
%U http://publichealth.jmir.org/2019/2/e12603/
%U https://doi.org/10.2196/12603
%U http://www.ncbi.nlm.nih.gov/pubmed/31094341